ARTICLE | Company News
Moderna Therapeutics, AstraZeneca deal
January 18, 2016 8:00 AM UTC
Moderna partnered exclusively with AstraZeneca to discover, develop and co-commercialize one mRNA therapeutic from each of two new joint immuno-oncology programs. Moderna’s Onkaido Therapeutics LLC (Cambridge, Mass.) arm will fund and conduct preclinical development up to IND submission. AZ’s MedImmune LLC unit will conduct early clinical development. ...